Clinical Trial Update: Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Polyglutamate Paclitaxel with gemcitabine or vinorelbine in advanced or recurrent non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)
• polyglutamate paclitaxel (not specified)

Snippet

Sponsor: CTI BioPharma | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED